Conversion of human fibroblasts into multipotent cells by cell-penetrating peptides

被引:3
|
作者
Kikuchi, Jiro [1 ]
Hayashi, Nakanobu [2 ]
Osada, Naoki [1 ]
Sugitani, Masahiko [3 ,4 ]
Furukawa, Yusuke [1 ]
机构
[1] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Gene Try Co, Itabashi Ku, Tokyo 1738610, Japan
[3] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738610, Japan
[4] Ageo Cent Gen Hosp, Pathol Div, Ageo, Saitama 3628588, Japan
关键词
Cell-penetrating peptide; Multipotent cell; Histone deacetylase; Lysine specific demethylase 1; Regenerative medicine; PLURIPOTENT STEM-CELLS; DELIVERY; GENE; INDUCTION; VECTOR; LSD1;
D O I
10.1016/j.bbrc.2019.08.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential application of human induced pluripotent stem cells (hiPSCs) brings great expectations to regenerative medicine. However, several safety concerns, such as oncogenic transformation, remain. A number of methods have been developed to produce hiPSCs with potentially reduced risks. Cell-penetrating peptides (CPPs) are expected to improve the efficiency of nonviral reprogramming by delivering biologically active molecules into cells. Here, we show that the transfection of CPPs alone into normal adult human fibroblasts generated embryonic body (EB)-like cell clusters in the absence of reprogramming factors. The CPP-generated cell clusters were positive for a set of multipotency markers and differentiated into endodermal, ectodermal, and mesodermal cells in vitro. These results suggest that CPPs converted normal human adult somatic cells into multipotent cells. Moreover, we show that CPPs dissociated histone deacetylase 1 and lysine-specific demethylase 1 from the promoter/enhancer regions of reprogramming factors to reactivate their expression. This is the first report of an easy and quick method for somatic cell reprogramming by CPPs and a novel mechanism of reprogramming. The potential application of CPP-generated multipotent cells resolves several concerns, especially safety issues, in regenerative medicine. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [1] Cellular Reprogramming Using Protein and Cell-Penetrating Peptides
    Seo, Bong Jong
    Hong, Yean Ju
    Do, Jeong Tae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03):
  • [2] Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells
    Chatterjee, Amit
    Ansar, Samdani
    Gopal, Divya
    Vetrivel, Umashankar
    George, Ronnie
    Narayanan, Janakiraman
    ACS OMEGA, 2022, 7 (19): : 16536 - 16546
  • [3] Cell-penetrating peptides transport therapeutics into cells
    Ramsey, Joshua D.
    Flynn, Nicholas H.
    PHARMACOLOGY & THERAPEUTICS, 2015, 154 : 78 - 86
  • [4] Human Protein 53-Derived Cell-Penetrating Peptides
    Suhorutsenko, Julia
    Eriste, Elo
    Copolovici, Dana-Maria
    Langel, Ulo
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2012, 18 (04) : 291 - 297
  • [5] Uptake Mechanism of Cell-Penetrating Peptides
    Gestin, Maxime
    Dowaidar, Moataz
    Langel, Ulo
    PEPTIDES AND PEPTIDE-BASED BIOMATERIALS AND THEIR BIOMEDICAL APPLICATIONS, 2017, 1030 : 255 - 264
  • [6] Predicting cell-penetrating peptides
    Hansen, Mats
    Kilk, Kalle
    Langel, Ulo
    ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (4-5) : 572 - 579
  • [7] siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells
    Furukawa, Kaori
    Tanaka, Masakazu
    Oba, Makoto
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (08)
  • [8] DESIGN OF CELL-PENETRATING PEPTIDES
    Bode, Saskia
    Thevenin, Marion
    Sagan, Sandrine
    Aussedat, Baptiste
    Aubry, Soline
    Jiao, Chen-Yu
    Lavielle, Solange
    Chassaing, Gerard
    Burlina, Fabienne
    BIOLOGICALLY ACTIVE PEPTIDES, 2011, 13 : 4 - 7
  • [9] Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee, Soo Hyeon
    Castagner, Bastien
    Leroux, Jean-Christophe
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (01) : 5 - 11
  • [10] Cell-penetrating peptides with intracellular organelle targeting
    Cerrato, Carmine Pasquale
    Kunnapuu, Kadri
    Langel, Ulo
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (02) : 245 - 255